Colorectal cancer screenings now recommended to start at age 45
March 21, 2022
The University of Cincinnati's Jordan Kharofa, MD, joined 55KRC's Simply Medicine radio show and podcast to discuss Colorectal Cancer Awareness Month.
March 21, 2022
The University of Cincinnati's Jordan Kharofa, MD, joined 55KRC's Simply Medicine radio show and podcast to discuss Colorectal Cancer Awareness Month.
March 17, 2022
WVXU featured the University of Cincinnati's Dr. Tahir Latif in a news story about how immunocompromised people are navigating life with most mask guidelines being lifted.
May 2, 2022
The University of Cincinnati's Alice Tang was featured in a Healio article discussing recently published research that administering an immunotherapy drug prior to surgery did not increase risks for patients with advanced oral cavity cancer.
May 27, 2022
The University of Cincinnati's John Breneman, MD, spoke with Imaging Technology News about the completion of enrollment of the FAST-01 trial, the first FLASH proton therapy trial completed in humans.
January 3, 2023
The University of Cincinnati's Caroline Billingsley, MD, was featured in a Q&A article on OncLive discussing the use of antibody-drug conjugates in ovarian cancer treatment.
March 2, 2023
The University of Cincinnati's Jordan Kharofa provided comments to the Wall Street Journal on a recent study that found a larger share of colorectal cancer patients are being diagnosed at a younger age and at a more dangerous stage of the disease.
September 29, 2022
Laser Focus World's Photonics Hot List highlighted the recent work of the University of Cincinnati's Jiajie Diao, PhD, who published research demonstrating a technique that uses light to help naturally balance mitochondria within cells.
September 21, 2022
Medical News Today highlighted recent research led by the University of Cincinnati's Pier Paolo Scaglioni, MD, that found targeting components of lipid metabolism and synthesis could lead to an effective lung cancer treatment.
June 9, 2022
Dermatology Times featured recent research by University of Cincinnati researchers that showed a low recurrence rate of nail squamous cell carcinoma when treated with surgical approaches other than amputation.
June 10, 2022
Healio highlighted clinical trial data presented by University of Cincinnati professor and Cincinnati Children's Hospital Medical Center oncologist Robin Norris on a new combination treatment for young patients with advanced-stage Hodgkin lymphoma.